You've read 9 articles this month

TPM is funded overwhelmingly by readers’ membership fees. More than 91% of our revenue is derived from memberships and reader contributions. The rest comes from advertising. As a fully independent organization, TPM has no corporate overlords. TPM is not beholden to or controlled by any outside interests. TPM was founded by a journalist and to this day its “business” side is staffed with former journalists whose primary mission is to create a sustainable environment for our reporters and editors to do great work.

Want better media? Support a better media company

  • Reader-funded
  • Unionized
  • Mission-driven

Creeping RFKJrism at HHS

Start your day with TPM.
Sign up for the Morning Memo newsletter

It’s still uncertain precisely how long the duration will be, but we’re getting fast emerging information that there appears to be an indefinite halt on the various meetings, review panels and so forth that keep the pipeline of medical research funding going in the U.S. This article in Science gives a broad overview. Put simply this just turns off the spigot of funding for a huge amount of cancer research as well as research across various other health fields and diseases. The article makes clear that there have been brief pauses before when a new administration takes office. But all signs suggest this is far more thorough-going and draconian. This comes after a similar halt to the weekly MMWR report which CDC sends to hospitals and doctors every week with information on flu, COVID and other infectious diseases.

I think we’re at the point in this where you can’t yet categorically say that this is being done for RFK Jr.-adjacent anti-research nuttery, but basically all signs point in that direction. And there is at least a temporary and disruptive halt to how health research gets funded in this country.

Meanwhile, on a totally different front, Jessica Valenti says that in the last two days Instagram has begun blocking the account of an organization focused on helping women find access to abortion medication.

Latest Editors' Blog
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Deputy Editor:
Editor at Large:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher & Digital Producer:
Senior Developer:
Senior Designer: